![Stephen Biggar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Biggar
Ordförande på
ACADIA PHARMACEUTICALS INC.
Förmögenhet: 2 M $ per 2026-05-31
Profil
Stephen R.
Biggar is Chairman at ACADIA Pharmaceuticals, Inc. since 2016, Chairman at TScan Therapeutics, Inc. since 2024, Independent Director at Kiniksa Pharmaceuticals Ltd. since 2015, Director at Notch Therapeutics, Inc., Independent Director at Kiniksa Pharmaceuticals International Plc since 2024, and Trustee at the University of Rochester.
Former roles include Director at BioCryst Pharmaceuticals, Inc. from 2005 to 2011, Director and Independent Director at Synageva BioPharma Corp.
from 2011 to 2015, Director at Vivelix Pharmaceuticals, Ltd., Director at Neurogene, Inc., and Partner at Baker Bros.
Advisors LP.
Education includes undergraduate studies at Rochester Christian University and graduate and doctorate degrees from Stanford University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-02-24 | 61 541 ( 0,04 % ) | 1 M $ | 2026-05-31 | |
0,03 % | 2026-04-06 | 12 546 ( 0,03 % ) | 606 975 $ | 2026-05-31 |
| 2026-03-31 | 0 ( -.--% ) | - $ | 2026-05-31 |
Aktiva positioner av Stephen Biggar
| Företag | Position | Start |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Ordförande | 2016-06-10 |
| TSCAN THERAPEUTICS, INC. | Ordförande | 2024-06-12 |
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Direktör/Styrelseledamot | 2015-10-01 |
Notch Therapeutics, Inc.
 Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops cell therapies for the treatment of diseases | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Stephen Biggar
| Företag | Position | Slut |
|---|---|---|
| SYNAGEVA BIOPHARMA CORP | Direktör/Styrelseledamot | 2015-06-22 |
Synageva BioPharma Corp. /Old/
 Synageva BioPharma Corp. /Old/ BiotechnologyHealth Technology Manufactures biopharmaceutical products | Direktör/Styrelseledamot | 2011-11-04 |
| BIOCRYST PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2011-10-10 |
Vivelix Pharmaceuticals, Ltd.
 Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Direktör/Styrelseledamot | - |
Stephen Biggars utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
59
Första gradens relationer
11
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 11 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Baker Bros. Advisors LP
 Baker Bros. Advisors LP Investment ManagersFinance BBA pursues a fundamentally driven approach to life sciences investing. The firm typically takes large, concentrated positions in the securities of life sciences companies with the potential for significant value creation over the long-term. They focus on public securities, but may, from time to time, recommend investments in private companies, life sciences and related healthcare intellectual property, royalty streams or other non-public investment opportunities. | Finance |
Synageva BioPharma Corp. /Old/
Synageva BioPharma Corp. /Old/ BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and delivers therapeutic medicines for patients suffering from cardiovascular diseases | Health Technology |
Vivelix Pharmaceuticals, Ltd.
Vivelix Pharmaceuticals, Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops cell therapies for the treatment of diseases | Health Technology |
